What Do Tesla Delivery Numbers Mean for Tesla Stock?
Tesla (NASDAQ:TSLA) released Q1 delivery numbers, showing a substantial slowdown…
Sell
20
ZVSA Quote, Financials, Valuation and Earnings
Last price:
$0.77
Seasonality move
:
-46.45%
Day range:
$0.77 - $1.03
52-week range:
$0.55 - $7.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.23x
Volume:
763.8K
Avg. volume:
4.4M
1-year change:
-89.73%
Market cap:
$1.9M
Revenue:
--
EPS (TTM):
-$113.75
Earnings Data
Next earnings date for ZVSA
--
Most recent earnings per share
-$0.57
Missed by $0.57
(Dec 31/2024)
Consensus Estimate
--
(Dec 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ZVSA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -$0.40 | -- |
| 12/31/2024 | Q4 | -- | -- | -$0.57 | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$2.43 | -$1.60 | -$0.83 |
| 06/30/2024 | Q2 | -- | -- | -$33.10 | -$3.75 | -$29.35 |
| 03/31/2024 | Q1 | -- | -- | -$45.30 | -$3.70 | -$41.60 |
| 12/31/2023 | Q4 | -- | -- | -$32.92 | -$21.40 | -$11.52 |
| 09/30/2023 | Q3 | -- | -- | -$30.18 | -$56.00 | $25.82 |
| 06/30/2023 | Q2 | -- | -- | -$1,694.12 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$1,358.80 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$177.37 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$515.54 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$35.00 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$54.17 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$28.45 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$27.16 | -- | -- |
ZyVersa Therapeutics Earnings Questions
-
How Much did ZyVersa Therapeutics Generate in Revenue Last Quarter?
ZyVersa Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did ZyVersa Therapeutics Beat Earnings Last Quarter?
ZyVersa Therapeutics announced earnings per share of -$0.57 which represents a miss of analyst forecast a -- per share.
-
Is ZyVersa Therapeutics Profitable?
ZyVersa Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for ZyVersa Therapeutics EPS Next Year?
ZyVersa Therapeutics's earnings are forecast to decrease from -$8.48 per share to -$12.43 per share next year representing a decrease of -98.86%.
-
When is ZyVersa Therapeutics's Earnings Date?
Currently, ZyVersa Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on July 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Chewy a Growth Stock to Buy?
It might be a surprise to learn that during the…
Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
42
KMX alert for Apr 12
CarMax [KMX] is up 2.87% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
Sell
30
CRSP alert for Apr 12
CRISPR Therapeutics AG [CRSP] is up 14.59% over the past day.
